Erratum: Functional-1149 G/T polymorphism of the prolactin gene in schizophrenia (Neuropsychobiology (2012) 65, (41-44) DOI: 10.1159/000329028);Functional -1149 G/T polymorphism of the prolactin gene in schizophrenia

Neuropsychobiology

Volumn 65, Issue 1, 2012, Pages 41-44

  Rybakowski, Janusz K ^a   Dmitrzak Weglarz, Monika ^a   Kapelski, Pawel ^a   Hauser, Joanna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

1149 G T polymorphism; Hyperprolactinemia; Prolactin; Prolactin gene; Schizophrenia

Indexed keywords

PROLACTIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL STUDY; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENOTYPE; HORMONE SYNTHESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 81155148721     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000339174     Document Type: Erratum

References (18)

1. Mathusoodanan S, Parida S, Jimenez C: Hyperprolactinemia associated with psychotropics - a review. Hum Psychopharmacol 2010; 25: 197-281.
2. Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, Keet IP, Gheorghe MD, Rybakowski JK, Galderisi S, Libiger J, Hummer M, Dollfus S, Lopez-Ibor JJ, Hranov LG, Gaebel W, Peuskens J, Lindefors N, Riecher-Rössler A, Grobbee DE, EUFEST Study Group: Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomized clinical trial. Lancet 2008; 371: 1085-1097. (Pubitemid 351418005)
3. Low WJ: Neuroendocrinology; in Kronenberg HM, Melmed S, Polonsky KS, Larsen PR (eds): Williams' Textbook of Endocrinology, ed 9. Philadelphia, Saunders Co, 2008, pp 85-295.
4. Owerbach D, Rutter WJ, Cooke NE, Martial JA, Shows TB: The prolactin gene is located on chromosome 6 in humans. Science 1981; 212: 815-816. (Pubitemid 11069382)
5. Evans AM, Petersen JW, Sekhon GS, De Mars R: Mapping of prolactin and tumor necrosis factor-beta genes on human chromosome 6p using lymphoblastoid cell deletion mutants. Somat Cell Mol Genet 1989; 15: 203-213. (Pubitemid 19155394)
6. Schwab SG, Mondabon S, Knapp M, Albus M, Hallmayer J, Borrmann-Hassenbach, M, Trixler M, Gross M, Schulze TG, Rietschel M, Lerer B, Maier W, Wildenauer DB: Association of tumor necrosis factor gene -G308A polymorphism with schizophrenia. Schizophr Res 2003; 65: 19-25. (Pubitemid 37410399)
7. Tochigi M, Zhang X, Umekage T, Ohashi J, Kato C, Marui T, Otowa T, Hibino H, Otani T, Kohda K, Liu S, Kato N, Tokunaga K, Sasaki T: Association of six polymorphisms of the NOTCH4 gene with schizophrenia in the Japanese population. Am J Med Genet B Neuropsychiatr Gen 2004; 128B:37-40. (Pubitemid 38849915)
8. Roig B, Virgos C, Franco N, Martorell L, Valero J, Costas J, Carracedo A, Labad A, Villella E: The discodin domain receptor 1 as a novel susceptibility gene for schizophrenia. Mol Psychiatry 2007; 12: 833-841. (Pubitemid 47347792)
9. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu DD, et al: Common variants conferring risk of schizophrenia. Nature 2009; 460: 744-747.
10. Stevens A, Ray D, Alansari A, Hajeer A, Thomson W, Donn R, Ollier WER, Worthington J, Davis JRE: Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus. Arthr Rheum 2001; 44: 2358-2366. (Pubitemid 32977504)
11. Lee YC, Raychaudhuri S, Cui J, De Vivo I, Ding B, Alfredsson L, Padyukov L, Costenbader KH, Seielstad M, Graham RR, Klareskog L, Gregersen PK, Plenge RM, Karlson EW: The PRL -1149 G/T polymorphism and rheumatoid arthritis susceptibility. Arthr Rheum 2009; 60: 1250-1254.
12. Yrigollen CM, Han SS, Kochelkova A, Babitz T, Chang JT, Volkmar FR, Leckman JF, Grigorenko EL: Genes controlling affiliative behavior as candidate genes for autism. Biol Psychiatry 2008; 63: 911-916.
13. First MB, Spitzer RL, Gibbon M, Williams J:Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCIDCV). Washington, American Psychiatric Press, 1996.
14. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
15. Pariante CM, Dazzan P, Danese A, Morgan KD, Brudaglio F, Morgan C, Fearon P, Orr K, Hutchinson G, Pantelis C, Velakoulis D, Jones PB, Leff J, Murray RM: Increased pituitary volume in antipsychotic-free and antipsychotic- treated patients of the Aesop first onset psychosis study. Neuropsychopharmacology 2005; 30: 1923-1931. (Pubitemid 41486417)
16. Mondelli V, Dazzan P, Gabilondo A, Toumikioti K, Walshe M, Marshall N, Schulze KK, Murray RM, McDonald C, Pariante CM: Pituitary volume in unaffected relatives of patients with schizophrenia and bipolar disorder. Psychoneuroendocrinology 2008; 33: 1004-1012.
17. Pariante CM: Pituitary volume in psychosis: the first review of the evidence. J Psychopharmacol 2008; 22(suppl 2):76-81.
18. Freeman ME, Kanyicska B, Lerant A, Nagy G: Prolactin: structure, function, and regulation of secretion. Pharmacol Rev 2000; 80: 1523-1631.